GeneCopoeia Genome-TALER custom TALEN and TALE-TF services

Wednesday, 06 March, 2013 | Supplied by: United Bioresearch Products Pty Ltd

GeneCopoeia Genome-TALER custom TALEN and TALE-TF services

Transcription activator-like (TAL) effectors have been used to create site-specific, gene-editing tools by fusing target sequence-specific TAL effectors to nucleases (TALENs), transcription factors (TALE-TFs) and other functional domains. These fusion proteins can recognise and bind chromosome target sequences specifically and execute their gene-editing functions. TAL effector domains recognise single nucleotides, allowing researchers to specifically target whichever sequence they want.

GeneCopoeia offers several services for designing, creating and validating TALENs, TALE-TFs and other TAL effectors-based targeted genomic modification tools.

Genome-TALER Engineer includes TAL effector design, engineering and sequencing.

Genome-TALER Value includes TAL effector design, engineering and sequencing, along with episomal-level functional validation: in vitro cleavage or surrogate reporter assay.

Genome-TALER Premium includes TAL effector design, engineering and sequencing, along with episomal-level functional validation: in vitro cleavage or surrogate reporter assay. It also includes chromosomal-level functional validation.

Advantages include: targeting any gene in any cell; highly sequence-specific genome target sites; flexible TALEN, TALE-TF and other TAL effector designs; choice of service level; cell-free or cell-based functional validations.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Meridian Bioscience Specimen-specific, inhibitor-tolerant master mixes

Scientists can skip DNA/RNA extraction with Meridian's inhibitor-tolerant, specimen-specific...

Molecular Devices microplate readers

A microplate reader is an essential instrument for a vast range of applications, from basic...

Dojindo Cytotoxicity LDH Assay Kit-WST

Dojindo's Cytotoxicity LDH Assay Kit-WST can be applied with or without supernatant transfer...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd